News
Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...
Government’s climate action plan does not prevent reliance on fossil fuels or bring Ireland in line with pollution limits ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...
Roche promised that its investments in the U.S. means it will export more medicines than it imports in the U.S.
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Swiss pharmaceutical giant Roche plans to invest $50 billion in the U.S. over the next five years, the latest major spending commitment by a big drugmaker as the industry faces President Trump's ...
Roche plans to invest $50 billion in the U.S. over the next five years, joining Swiss rival Novartis in expanding its footprint in the country amid President Trump's tariff threats.
1d
Zacks Investment Research on MSNNovartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...
A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...
Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...
U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results